MedinCell CEO on Long-Acting Drugs & France’s $1B Biotech Club | Christophe Douat | E62
Christophe has run MedinCell since 2009, when it was eight people in a converted garage....
Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61
Christian Angermayer became a multimillionaire before turning 25 thanks to the merger of Alnylam with...
ImCheck ex-CEO Pierre d’Epenoux talks Fundraising, France and Oncology’s Next Wave | E60
After ImCheck’s inception in 2015, Pierre took the helm through clinical development and guided the...
![CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]](https://flot.bio/wp-content/uploads/2026/06/Website-Thumbnail-PathoQuest-1080x648.avif)
CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]
Founded in 2010, the Institut Pasteur spinout PathoQuest sold to top CRO Charles River for...
Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy | E58
When Hervé joined Incyte in 2014, the launch of lead product Jakafi in the US...
Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57
We admire the mountains of Austria with the co-founder of Curie.Bio, a founder-friendly fund that...
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far....
![Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]](https://flot.bio/wp-content/uploads/2026/04/Website-Thumbnail-IMMUNOTHEP-1080x648.avif)
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Antibiotic-resistant superbugs could become a greater threat than cancer. Bruno and Pedro at the startup...
António Portela, Bial 🇵🇹 | Parkinson’s, Family-Owned Biotech | E54
We dive into Bial’s meteoric journey from a small pharmacy in Porto to Portugal’s biggest...
Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly...
